Zastosowanie preparatów bzu czarnego w leczeniu infekcji układu oddechowego Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
mar 31, 2022
Słowa kluczowe:
Sambucus nigra, bez czarny, infekcje dróg oddechowych
##plugins.themes.bootstrap3.article.main##
Abstrakt
Bez czarny jest farmaceutykiem roślinnym stosowanym w leczeniu wspomagającym wielu schorzeń, przede wszystkim zakażeń górnych dróg oddechowych. Ekstrakty owoców bzu łagodzą objawy infekcji i skracają czas ich trwania, hamują również namnażanie się niektórych wirusów i bakterii.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Maruszczak , P., Woźniak , K., Woźniak , M., & Doniec , Z. (2022). Zastosowanie preparatów bzu czarnego w leczeniu infekcji układu oddechowego . Medycyna Faktów , 15(1(54), 46-49. https://doi.org/10.24292/01.MF.0122.6
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Harnett J, Oakes K, Carè J et al. The effects of Sambucus nigra berry on acute respiratory viral infections: A rapid review of clinical studies. Adv Integr Med. 2020; 7(4): 240-6.
2. Sapilak B. Sambucus nigra L. – przegląd badań naukowych. Medycyna Faktów. 2019; 1(42): 19-25.
3. Porter RS, Bode RF. A Review of the Antiviral Properties of Black Elder (Sambucus nigra L.) Products. Phytother Res. 2017; 31(4): 533-54.
4. Nagai T, Miyaichi Y, Tomimori T et al. Inhibition of influenza virus sialidase and anti-influenza virus activity by plant flavonoids. Chem Pharm Bull (Tokyo). 1990; 38(5): 1329-32.
5. Roschek B, Fink RC, McMichael MD et al. Elderberry flavonoids bind to and prevent H1N1 infection in vitro. Phytochemistry. 2009; 70(10): 1255-61.
6. Krawitz C, Mraheil MA, Stein M et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011; 11: 16.
7. Izzo A, di Carlo G, Biscardi D et al. Biological screening of Italian medicinal plants for antibacterial activity. Phytoter Res.1995; 9(4): 281-6.
8. Silveira D, Prieto-Garcia JM, Boylan F et al. COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Front Pharmacol. 2020; 11: 581840.
9. Przybylska-Balcerek A, Szablewski T, Szwajkowska-Michałek L et al. Sambucus Nigra Extracts-Natural Antioxidants and Antimicrobial Compounds. Molecules. 2021; 26(10): 2910.
10. Hearst C, Mccollum G, Nelson D et al. Antibacterial activity of elder (Sambucus nigra L.) flower or berry against hospital pathogens. J Med Plants Res. 2010; 4: 1805-9.
11. Bown D. Encyclopaedia of herbs and their uses. Dorling Kindersley, London 1995.
12. Gollucke AP, Peres RC, Odair A et al. Polyphenols: A nutraceutical approach against diseases. Recent Pat Food Nut Agric. 2013; 5(3): 214-9.
13. Barak V, Birkenfeld S, Halperin T et al. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Isr Med Assoc. 2002; J4(11 Suppl): 919-22.
14. Barak V, Halperin T, Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. Eur Cytokine Netw. 2001; 12(2): 290-6.
15. Ho GT, Wangensteen H, Barsett H. Elderberry and Elderflower Extracts, Phenolic Compounds, and Metabolites and Their Effect on Complement, RAW 264.7 Macrophages and Dendritic Cells. Int J Mol Sci. 2017; 18(3): 584.
16. Zakay-Rones Z, Varsano N, Zlotnik M et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995; 1(4): 361-9.
17. Zakay-Rones Z, Thom E, Wollan T et al. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004; 32(2): 132-40.
18. Kong F. Pilot clinical study on a proprietary elderberry extract: efficacy in addressing influenza symptoms. Online J Pharmacol Pharmacokinet. 2009; 5: 32-43.
19. Tiralongo E, Wee SS, Lea RA. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Nutrients. 2016; 8(4): 182.
20. Hawkins J, Baker C, Cherry L et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta- analysis of randomized, controlled clinical trials. Complement Ther Med. 2019; 42: 361-5.
21. Kronbichler A, Effenberger M, Eisenhut M et al. Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view. Autoimmun Rev. 2020; 19(7): 102570. http://doi.org/10.1016/j.autrev.2020.102570.
22. Auwerx J, François KO, Vanstreels E et al. Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate- binding agents and polyanions. Antiviral Res. 2009; 83(1): 61-70.
23. Chan VS, Chan KY, Chen Y et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet. 2006; 38(1): 38-46.
24. Keyaerts E, Vijgen L, Pannecouque C et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007; 75(3): 179-87.
2. Sapilak B. Sambucus nigra L. – przegląd badań naukowych. Medycyna Faktów. 2019; 1(42): 19-25.
3. Porter RS, Bode RF. A Review of the Antiviral Properties of Black Elder (Sambucus nigra L.) Products. Phytother Res. 2017; 31(4): 533-54.
4. Nagai T, Miyaichi Y, Tomimori T et al. Inhibition of influenza virus sialidase and anti-influenza virus activity by plant flavonoids. Chem Pharm Bull (Tokyo). 1990; 38(5): 1329-32.
5. Roschek B, Fink RC, McMichael MD et al. Elderberry flavonoids bind to and prevent H1N1 infection in vitro. Phytochemistry. 2009; 70(10): 1255-61.
6. Krawitz C, Mraheil MA, Stein M et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011; 11: 16.
7. Izzo A, di Carlo G, Biscardi D et al. Biological screening of Italian medicinal plants for antibacterial activity. Phytoter Res.1995; 9(4): 281-6.
8. Silveira D, Prieto-Garcia JM, Boylan F et al. COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Front Pharmacol. 2020; 11: 581840.
9. Przybylska-Balcerek A, Szablewski T, Szwajkowska-Michałek L et al. Sambucus Nigra Extracts-Natural Antioxidants and Antimicrobial Compounds. Molecules. 2021; 26(10): 2910.
10. Hearst C, Mccollum G, Nelson D et al. Antibacterial activity of elder (Sambucus nigra L.) flower or berry against hospital pathogens. J Med Plants Res. 2010; 4: 1805-9.
11. Bown D. Encyclopaedia of herbs and their uses. Dorling Kindersley, London 1995.
12. Gollucke AP, Peres RC, Odair A et al. Polyphenols: A nutraceutical approach against diseases. Recent Pat Food Nut Agric. 2013; 5(3): 214-9.
13. Barak V, Birkenfeld S, Halperin T et al. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Isr Med Assoc. 2002; J4(11 Suppl): 919-22.
14. Barak V, Halperin T, Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. Eur Cytokine Netw. 2001; 12(2): 290-6.
15. Ho GT, Wangensteen H, Barsett H. Elderberry and Elderflower Extracts, Phenolic Compounds, and Metabolites and Their Effect on Complement, RAW 264.7 Macrophages and Dendritic Cells. Int J Mol Sci. 2017; 18(3): 584.
16. Zakay-Rones Z, Varsano N, Zlotnik M et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995; 1(4): 361-9.
17. Zakay-Rones Z, Thom E, Wollan T et al. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004; 32(2): 132-40.
18. Kong F. Pilot clinical study on a proprietary elderberry extract: efficacy in addressing influenza symptoms. Online J Pharmacol Pharmacokinet. 2009; 5: 32-43.
19. Tiralongo E, Wee SS, Lea RA. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Nutrients. 2016; 8(4): 182.
20. Hawkins J, Baker C, Cherry L et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta- analysis of randomized, controlled clinical trials. Complement Ther Med. 2019; 42: 361-5.
21. Kronbichler A, Effenberger M, Eisenhut M et al. Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view. Autoimmun Rev. 2020; 19(7): 102570. http://doi.org/10.1016/j.autrev.2020.102570.
22. Auwerx J, François KO, Vanstreels E et al. Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate- binding agents and polyanions. Antiviral Res. 2009; 83(1): 61-70.
23. Chan VS, Chan KY, Chen Y et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet. 2006; 38(1): 38-46.
24. Keyaerts E, Vijgen L, Pannecouque C et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007; 75(3): 179-87.